SiFLUC (sodium)

SiFLUC (sodium) targets firefly luciferase and has no complementarity in mammalian genome. siFLUC (sodium) can be used as the control oligonucleotide control for CEBPA-51.

Product Specifications

UNSPSC

12352208

Target

Others

Type

Oligonucleotides

Related Pathways

Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/sifluc-sodium.html

Purity

94.91

Solubility

10 mM in H2O

Smiles

[siFLUC(sodium)]

Molecular Weight

14452.56

References & Citations

[1]Reebye V, Huang KW, Lin V, et al. Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. Oncogene. 2018;37 (24) :3216-3228. |[2]Ferreiro I, Genevois C, Konate K, et al. In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery. Pharmaceutics. 2021;13 (5) :749. |[3]Vaissière A, Aldrian G, Konate K, et al. A retro-inverso cell-penetrating peptide for siRNA delivery. J Nanobiotechnology. 2017;15 (1) :34.